CytomX Therapeutics, Inc. (CTMX)
收市後：
| 前收市價 | 5.1300 |
| 開市 | 4.4000 |
| 買盤 | 4.4800 x 100 |
| 賣出價 | 4.5200 x 100 |
| 今日波幅 | 4.0700 - 4.7400 |
| 52 週波幅 | 1.0400 - 5.8500 |
| 成交量 | |
| 平均成交量 | 4,322,711 |
| 市值 | 304.793M |
| Beta 值 (5 年，每月) | 1.02 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.0100 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 2.90 |
ZacksCytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?
CytomX Therapeutics (CTMX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Insider MonkeyCytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript March 11, 2024 CytomX Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter 2023 Financial […]
ZacksCytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -50% and 13.90%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
